Home|About This Site|About Us|Maps & Parking|Giving|Contact Us|Careers|Med-U-Nurse
Medical University Hospital home pageClinical Neurobiology Laboratory
Search:

About the Clinical Neurobiology Laboratory

Quick Clicks
Contact Us
%CDT
Testing Menu
red line


Patients and Visitors
Medical Services
Health Information
Community Events
Health Professionals
Home > Institute of Psychiatry > Psychiatric Services > Clinical Neurobiology Laboratory > images > %CDT Articles
%CDT Articles

email icon

printer icon

print

ArticlesArArticles

Addiction Specialists

Anton, R. F., Dominick, C., Bigelow, M., Westby, C., & CDTect Study Group, (2001).  Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-Glutamyltransferase.  Clinical Chemistry, 47(10), 1769-1775. 

Anton R. F., Lieber C., Tabakoff B., & CDTect Study Group, (2002).  Carbohydrate-Deficient Transferrin and gamma-Glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.  Alcoholism: Clinical and Experimental Research, 26(8), 1215-1222

Center for Substance Abuse Treatment, (2006).  The role of biomarkers in the treatment of alcohol use disorders.  Substance Abuse Treatment Advisory, 5(4), 1-8. 

Cluver, J. S., Miller, P.M., & Anton, R. F., (2007). Case Studies of the Utility of Serum Carbohydrate-Deficient Transferrin (%CDT) in the Clinical Management of Alcoholics. Journal of Addition Medicine, 1(1), 44-47.

Dillie, K. S., Mundt, M., French, M. T., & Fleming, M. F., (2005).  Cost-benefit analysis of a new alcohol biomarker, carbohydrate-deficient transferrin, in a chronic ilness primary care sample.  Alcoholism: Clinical And Experimental Research, 29(11), 2008-2014.

Fleming, M. F., Anton, R. F., & Spies, C. D., (2004).  A review of genetic, biological, pharmacological, and clinical factors that affect Carbohydrate-Deficient Transferrin levels.  Alcoholism: Clinical and Experimental Research, 28(9), 1347-1355.

Miller, P. M., & Anton, R. F., (2004).  Biochemical alcohol screening in primary healthcare.  Addictive Behaviors, 29, 1427-1437.

Miller, P. M., Dominick, C. S., & Anton, R. F., (2004).  Carbohydrate-deficient transferrin test: a tool for detecting alcohol abuse.  Current Psychiatry, 5(6), 80-87.

Surgery and Internal Medicine

Miller, P. M., Spies, C., Neumann, T., Javos, M. A., Hoyumpa, A. M., Roache, J., Webb, A., Kashi, M., Sharkey, F. E., Anton, R. F., Egan, B. M., Basile, J., Nguyen, S., Fleming, M. F., Dillie, K. S., (2006).  Alcohol biomarker screening in medical and surgical settings.  Alcoholism: Clinical and Experimental  Research, 30(2), 185-193. 

Spies, C. D., Kissner, M., Neumann, T., Blum, S., Voigt, C., Funk, T., Runkel, N., & Pragst, F., (1998).  Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit stay in traumatized men.  Alcohol & Alcoholism, 33(6), 661-669.

(Note: The free  Adobe Acrobat Reader® is required to view the following documents.)

Clinical Neurobiology Laboratory
67 President St. PH144
Charleston, SC 29425
Ph. (843) 792-5441 Fax (843) 792-7371
E-mail: cnl@musc.edu

Page last updated: 02/06/08
privacy statements | 

disclaimer

 | accessibility |  press room |  find a doctor | site map | e-newsletters
© 2008 Medical University of South Carolina
Health on the Net Foundation sealWe subscribe to the
HONcode Principles
Verify Here